ICU Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ICU Medical generated cash of $166,201,000, which is more than the previous year. Cash used in financing activities reached the amount of -$35,979,000 last year. Net change in cash is therefore $45,438,000.
Cash Flow
| 2014 | 60.64M | -21.75M | 19.34M |
|---|---|---|---|
| 2015 | 54.86M | -11.24M | 25.01M |
| 2016 | 89.94M | 16.28M | 2.47M |
| 2017 | 154.42M | -266.87M | -44.34M |
| 2018 | 160.21M | -103.37M | 8.02M |
| 2019 | 101.91M | -166.88M | -10.90M |
| 2020 | 222.75M | -98.13M | -40K |
| 2021 | 267.53M | -90.68M | -16.87M |
| 2022 | -62.12M | -1.90B | 1.63B |
| 2023 | 166.20M | -87.94M | -35.97M |
ICUI Cash Flow Statement (2014 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 208.78M | 552.82M | 396.09M | 268.67M | 344.78M | 290.07M | 445.08M | 336.16M | 275.81M | 226.02M |
Operating activities | ||||||||||
Net income | -29.65M | -74.28M | 103.13M | 86.87M | 101.03M | 28.79M | 68.64M | 63.08M | 44.98M | 26.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 228.79M | 235.15M | 89.69M | 94.84M | 85.21M | 74.73M | 66.56M | 19.05M | 18.07M | 19.44M |
Stock-based compensation expense | 40.56M | 36.02M | 27.34M | 23.95M | 21.91M | 0 | 19.35M | 15.24M | 12.82M | 9.59M |
| Deferred income tax benefit | 40.56M | 36.02M | 27.34M | 23.95M | 21.91M | 0 | 19.35M | 15.24M | 12.82M | 9.59M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 48.63M | -19.15M | 13.75M | 78.04M | -23.68M | -76.74M | -54.53M | 744K | -20.51M | 4.91M |
Inventories | -6.07M | -201.09M | 20.81M | 19.19M | -24.99M | -21.77M | 181.69M | -5.50M | -8.33M | -3.83M |
Accounts payable | -68.30M | 37.47M | 2.34M | -46.41M | -2.69M | 23.27M | 46.64M | -463K | 3.11M | -621K |
Cash generated by operating activities | 166.20M | -62.12M | 267.53M | 222.75M | 101.91M | 160.21M | 154.42M | 89.94M | 54.86M | 60.64M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -3.39M | -13.28M | -32.82M | -26.04M | -30.49M | -24.74M | -118.38M | -56.13M | -93.58M |
Investments In Property Plant And Equipment | -83.89M | -99.32M | -81.16M | -100.39M | -106.04M | -100.77M | -79.68M | -24.55M | -13.93M | -17.59M |
Acquisitions Net | 0 | -1.84B | -14.45M | -8.38M | -76.13M | -1.3M | -162.44M | -2.58M | -27.81M | -989K |
Cash generated by investing activities | -87.94M | -1.90B | -90.68M | -98.13M | -166.88M | -103.37M | -266.87M | 16.28M | -11.24M | -21.75M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 8.78M | 9.37M | 13.19M | 0 | 0 | 0 | 2.36M | 0 | 2.48M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -9.35M | -10.88M | -8.33M | -12.87M | -18.63M | -6.25M | -4.05M | -17.23M | -1.52M | -5.83M |
Repayments of term debt | -30.65M | 1.64B | -607K | -150.35M | 0 | 0 | -75M | 0 | 0 | 0 |
Cash used in financing activities | -35.97M | 1.63B | -16.87M | -40K | -10.90M | 8.02M | -44.34M | 2.47M | 25.01M | 19.34M |
Net Change In Cash | 45.43M | -344.04M | 156.73M | 127.42M | -76.11M | 54.70M | -155.01M | 108.91M | 60.35M | 49.79M |
Cash at end of period | 254.22M | 208.78M | 552.82M | 396.09M | 268.67M | 344.78M | 290.07M | 445.08M | 336.16M | 275.81M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |